The pentacyclic acridine RHPS4 is a highly potent and specific G-quadruplex (G4) ligand, which binds and stabilizes telomeric G4 leading to the block of the replication forks at telomeres and consequently to telomere dysfunctionalization. In turn, the cell recognizes unprotected telomeres as DNA doublestrand breaks with consequent activation of DNA repair response at telomeres, cellular growth impairment, and death. Data from the literature showed the capability of this compound to sensitize U251MG glioblastoma radioresistant cell line to X-rays sparsely ionizing radiations. In the present paper, it was investigated whether RHPS4 is also able to increase the effect of clinical carbon ion beams (cells irradiated in the middle of a spread-out Bragg peak, in the energy range of 246-312 MeVÁlm
Introduction
The current state of hadrontherapy worldwide shows a situation of constant progress and the excellent results obtained in Japan with carbon ion therapy have encouraged the spread of systems using these particles to Europe and China [1] . Beside the better physical dose distribution, carbon ions demonstrated a variety of positive radiobiological properties related to the microscopic distribution of energy deposition that, in turn, determines an increased relative biological effectiveness (RBE) which can be calculated between 2 and 5 depending on the cell line as well as the endpoint analyzed [2, 3] . Other than a higher relative biological effectiveness, carbon ions show a lower oxygen enhancement ratio, reduced repair capacity, and decreased cell cycle dependence, suggesting a potential advantage of hadrontherapy compared with conventional radiotherapy for eradication of radioresistant tumors.
Radiotherapy is one of the standard treatments for glioblastoma multiforme (GBM), nevertheless conventional RT with or without chemotherapy is not sufficient to increase the overall survival of patients suffering from this radioresistant tumor and the poor prognosis for GBM patients has improved minimally over decades. As suggested by an exploratory retrospective study [4] and the Japanese experience [5] , carbon ions are considered to be a good therapeutic option for GBM since they are able to satisfy both the need to reduce tumor radioresistance and to minimize the irradiated normal tissue. Two clinical trials evaluating carbon ion treatment for GBM started at the Heidelberg Ion-Beam Therapy Center (Germany) [6] .
To further improve radiotherapy outcome, the efficacy and mechanisms of different radiosensitizer agents have been explored in GBM cells/murine systems for conventional photon radiation (gamma-rays, X-rays). The different settings tested include Temozolomide, EGFR antagonists, HADAC inhibitors, targeting of checkpoints, gadolinium-bases nanoparticles, Polo like kinase-targeting molecules, G-quadruplex (G4)-stabilizing ligands, etc. In particular, in the last years a considerable attention has been concentrated to small molecules G4-ligands, which were proven to bind to G4 secondary structures physiologically present in the promoters of different genes (e.g., c-Myc [7] , PDGFR-b [8] , c-Myb [9] , VEGFR-2 [10] , CD133 and CD44 [11] ) and at the G-rich overhang of telomeric DNA [12] [13] [14] . In particular, as a result of telomeric interaction with G4-ligand, a replication block may occur, which in turn lead to impairment of telomerase binding to telomere sequences, telomere loss, and dysfunction. For this reason, drugs, including G4-ligands, affecting telomere structure and/or telomerase activity, are currently seen as an attractive tool in oncology [15] . RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl] acridinium methosulfate), trough the specific binding of G4, causes alteration in the telomeric architecture leading to telomere uncapping and detachment of shelterin proteins prompting telomere dysfunction, activation of DNA damage response, chromosome end-to-end fusions, cell cycle arrest and cell growth impairment as evaluated in diverse in vitro and in vivo systems [7, [16] [17] [18] . Interestingly, RHPS4 as a single treatment seems to be more effective in tumor cells than in normal counterparts [18] [19] [20] [21] , probably thanks to different telomeric status of normal and cancer cells [21, 22] . Data from the literature showed the capability of submicromolar concentrations of RHPS4 to radiosensitize X-ray-exposed U251MG GBM cells in a synergistic manner [21] . In the present paper we evaluated whether RHPS4 could also sensitize U251MG cells exposed to clinical scanning carbon ion beams in terms of increased cell killing, delayed c-H2AX foci disappearance, chromosome-aberration induction, and cell cycle arrest.
Results

RHPS4 treatment increases cellular sensitivity to ionizing radiation
Surviving fraction experiments in the 0.5-4 Gy dose range were performed in order to evaluate the RHPS4 capability to radiosensitize U251MG cells to carbon ions (Fig. 1A) . In accordance with previously published data, we found that U251MG cells displayed high intrinsic radioresistance [23] , showing a 21% surviving fraction after 2 Gy of carbon ions. Treatment with RHPS4 determined per se a reduction of cell survival in unirradiated cells, displaying a plating efficiency that is 82% AE 0.12% of the untreated control (Fig. 1A) . Interestingly, the comparison between survival curves obtained after irradiation alone or after the combo treatment showed a synergistic effect as tested using the model proposed by Lutterbojer and coauthors [24] (Fig. 1B) . Relative Biological Effectiveness (RBE) was calculated by the comparison with previously published data [21] obtained after RHPS4 and X-rays (250 KV, 6 mA, 0.53 GyÁmin À1 ) combined treatments ( Fig. 1C,D) . Interestingly, in RHPS4 untreated cells we reported an RBE for carbon ions around 2.5, whereas RBE for RHPS4 and carbon ions combined treatment was about 5.3. Moreover, surviving fraction as evaluated after 2 Gy of carbon ions moved from 21% in untreated cells to 10% in RHPS4 pretreated cells (Fig. 1A) and the sensitization enhancement ratio (SER) value, which was calculated using the 10% survival dose, was about 1.45. As previously reported for X-rays, surviving fraction at 2 Gy was 53% and after RHPS4 pretreatment decreased to 20%, whereas SER value was approximately 1.9. Overall, data indicated that RHPS4 maintains its ability to synergistically radiosensitize U251MG cells, independently from radiation quality.
RHPS4 induces a DNA repair kinetics delay in U251MG exposed to carbon ions Control and 0.2 lM RHPS4 treated samples were exposed to 2 and 4 Gy and then harvested after 1, 4, and 24 h. The yield of DNA damage as evaluated 1 h after C-ions irradiation was similar in RHPS4-treated anduntreated cells (data not shown). However, RHPS4-treated cells displayed a slower DNA repair kinetics if compared with cells exposed to the radiation alone (Fig. 2) . Indeed, 4 h after irradiation, a significant difference in the residual number of cH2AX foci was observed after both 2 and 4 Gy of carbon ions (Fig. 2 A-D) , whereas no significant difference was found for 53BP1. Interestingly, 24 h after the exposure to both doses of carbon ions, RHPS4 treatment determined a significantly higher remaining fraction of both cH2AX and 53BP1 foci, indicating a subset of residual unrepaired lesion. Representative images are reported in Fig. 2E .
Combined treatment increases chromosomal exchanges, and in particular dicentrics, in U251MG cells
Results obtained from multicolor FISH (mFISH) analysis revealed that genome-wide gross chromosomal exchanges were more abundant in combined treated samples (2.25 and 2.93 exchange/cell for 1 and 2 Gy, respectively) than in samples exposed solely to carbon ions (1.76 and 2.4 exchanges/cell for 1 and 2 Gy, respectively). Interestingly, breaks frequency per chromosome was higher in combo-treated samples than in sample exposed only to carbon ions ( Fig. 3A-C ; in Fig. 3D , the total DNA Mbp of each chromosome, corrected for multiple chromosome copies present in the U251MG karyotype, are reported). In particular, we observed a dose-and RHPS4-dependent increase in the complex exchanges frequency and in the C-ratio (Fig. 3E,F) . Moreover, RHPS4 pretreatment did not increase only the frequency of complex exchanges but also their complexness as shown by distributions of number of breaks per complex exchange (Fig. 3G) . To address the possible involvement of telomeres in the generation of chromosomal exchanges observed, pan-centromeric/ telomeric FISH experiments were performed. Data indicated that the frequency of dicentrics and telomere fusions were higher in combined treated samples (0.51 dicentrics/cell and 0.41 fusions/cell at 1 Gy and 1.31 dicentrics/cell and 0.50 fusions/cell at 2 Gy) than in samples exposed solely to carbon ions (0.39 dicentrics/ cell and 0.0014 fusions/cell at 1 Gy and 1.29 dicentrics/ cell and 0.022 fusions/cell at 2 Gy) (Fig. 4A,B) , indicating the participation of dysfunctional telomere in the generation of chromosomal aberration observed in combo-treated samples (example of a telomere fusion is reported in Fig. 4C ).
Combined radiation and drug treatment induce cell cycle block/delay in U251MG
Cell cycle analysis was performed in samples harvested 24 h and 48 h after irradiation. No differences in cell cycle phase distributions were detected comparing samples pretreated or not with 0.2 lM RHPS4 for 5 days confirming data previously reported for U251MG ( Fig. 5A and B) [21] . After carbon irradiation cells pretreated with RHPS4 became strongly arrested in G 2 -phase at doses higher than 1 Gy (no differences were reported in samples exposed to Remaining fraction of cH2AX foci after 2 and 4 Gy of carbon ions as evaluated after 1, 4, and 24 h. (E) Representative images of nuclei coimmunostained with antibodies against 53BP1 (green dots) and cH2AX (red dots) and counterstained with DAPI. The error bars represent standard deviation (SD) determined from three (n = 3) independent experiments. Student's t-test, *P < 0.05, **P < 0.01. 0.5 Gy, data not shown). In particular, significant differences were observed comparing samples exposed solely to 1 and 2 Gy of carbon ions to samples irradiated with the same doses in the presence of RHPS4 pretreatment (28 vs 37.7% after 1 Gy, 30.5 vs 46.4% after 2 Gy and 45.9 vs 64.2 after 4 Gy). No The error bars represent standard deviation (SD) determined from two (n = 2) independent experiments. Student's t-test, *P < 0.05, **P < 0.01. significant differences in the percentage of cells in S-phase were observed, whereas the percentage of G 1 cells decrease in a dose-dependent manner, especially in samples treated with RHPS4 (Fig. 5) . As previously reported for X-rays, the G 2 phase block was completely overcome 48 h after irradiation. No evidences of sub-G 1 populations were observed.
Discussion
Unique physical features of carbon ions may allow them to be more effective than photons in killing radioresistant tumors with minor dependence of the level of tumor oxygenation and sparing of normal healthy tissues. For what concern the exposure to the carbon ions alone we found, for comparable LET conditions, survival values for U251MG cells in good agreements with data published by others for the same cell line (survival of about 20% and 4% after 2 and 4 Gy of carbon ions (40 keVÁlm À1 , 290 MeVÁn
À1
), respectively) [25] . These in vitro observations were also supported by randomized phase II study evaluating a carbon ion vs a proton boost applied after combined radio-chemotherapy with temozolomide in patients with primary glioblastoma [4] .
To our knowledge the studies on the potential of these molecules as radiosensitizers are very scanty and restricted to only G4 ligand TAC (N-methylated triflate derivatives of 4,6-bis-(6-(acrid-9-yl)-pyridin-2-yl)-pyrimidine) [26] , platinum-derived G4-ligand Pt-ctpy [27] , and RHPS4 [21] in combination with conventional sparsely ionizing radiations. In particular, using a first-generation G4-ligand TAC, it was shown its capability to enhance in vitro c-rays-induced killing in SF763 and SF767T human radioresistant telomerase-positive GBM cell lines [26] . Similar results were obtained using a second-generation G4-ligand named Pt-ctpy that strongly enhances the sensitivity of GBM and nonsmall cell lung cancer cells (NSCLC) to ionizing radiation both in vitro and in SF763-GBM-xenografted mice [27] . Concerning the combined effect of RHPS4 and X-rays in cultured U251MG cells, evidence have been published which link dysfunctional telomeres with increased cell killing, persistent DNA damage, and chromosome aberrations [21] . Notably, this drug was proven to be very effective also in the radiosensitization of mice xenograft derived from U251MG cells in combination with X-rays (F. Berardinelli, M. Tanori, D. Muoio, M. Buccarelli, A. di Masi, S. Leone, L. Ricci Vitiani, M. Mancuso, A. Antoccia, unpublished data).
Although radiosensitizing agents sometimes show differential effects in combination with low-vs high-LET radiation [28, 29] , this is not the case of RHPS4 and results presented in this paper, support a role for this molecule as radiosensitizer also for charged particles. Notably, similar to photons [21] , carbon ions interact synergistically with RHPS4 with a twofold reduction of the cell survival as evaluated at the dose of 2 Gy (the dose used daily in standard care treatment of GBM patients). Moreover, survival data indicate an RBE for carbon ions near to 2.5 that increased to 5.3 when cells were pretreated with RHPS4. Reduced cell survival in combo-treated samples was accompanied by a delay in DNA double-strand breaks (DSB) repair Fig. 4 . Frequency of dicentrics derived from DSB-DSB fusions (dic), telomeric fusions (TF) + telomeric-DSB fusions (T-DSB), and total dicentrics (Total) in single and combined treated samples exposed to 1 (A) and 2 Gy (B) of carbon ions. (C) Examples of a dicentric with telomeric signals at the fusion site (telomere fusion). The error bars represent standard deviation (SD) determined from two (n = 2) independent experiments. Student's t-test, *P < 0.05, **P < 0.01, ***P < 0.001.
and by a very strong blockage of the cell cycle with an accumulation in the G 2 phase suggesting the interference of dysfunctional telomeres with accurate DSB repair [30, 31] and subsequent activation of G 2 /M checkpoint. Same results were previously observed with photons [21, 26] . RHPS4 synergistic response in combination with IR is also supported by genome-wide chromosomal aberration analysis through mFISH. In untreated and RHPS4-treated samples, the frequency of breakpoints per chromosome had comparable values ranging between 0.05 and 0.2 breaks/chromosome. As expected, in IR-treated samples, the frequency of breaks per chromosome increased with chromosome length and IR dose (Fig. 3A-C) , indicating that IR interacts with chromosomes in a stochastic manner and that longer chromosome had a major chance to be hit than shorter ones [32, 33] . In combo-treated samples, slopes remained very similar to those of samples exposed to the only IR but, interestingly, frequencies of breaks shifted up significantly and in a dose-specific manner. A general consideration that can be evinced from these data is that RHPS4 increases the frequency of carbon ion-induced chromosomal exchange in an IR dose-dependent manner, at least in the dose range investigated in the present paper.
In addition, mFISH experiments revealed a higher frequency of complex chromosomal rearrangements in combo-treated samples, as shown by the increase in complex exchange frequency and in C-ratio value. Increase in the complexity of chromosomal rearrangement could be explained by the interaction between DSBs generated by the carbon ions and dysfunctional telomeres generated by the action of RHPS4 and fit very well with the hypothesis of a dysfunctional telomeredriven increase of radio-induced chromosomal instability. To confirm the involvement of telomeres in the generation of chromosomal exchanges observed, pancentromeric and telomeric staining was performed. Data indicated that combined treatment increased the frequency of dicentrics and aberrations involving telomeres (telomere-DSB + telomere-telomere fusions) and confirmed the role of telomere dysfunction in the generation of lethal chromosomal aberrations and cell death [30, 31] .
Overall, these results reinforce the notion that telomere dysfunctionalization through the use of G4 ligands is an excellent strategy for tumor radiosensitization and so far as we know, demonstrate for the first time that the RHPS4-mediated radiosensitization effect is independent to the quality of radiation used.
Although RHPS4 will probably never enter into clinical trial due to its cardiac toxicity as shown in an in vivo guinea pig model [34] , it remains a very important paradigm to prove the efficacy of telomere-specific G4 ligands in the radiosensitization of tumors resistant to radiotherapy. In this respect the development of new RHPS4 derivatives displaying minimal off-target effects and improved toxicological profiles [20, 34] may open the way to future clinical testing and applications.
Experimental procedures
Cell culture conditions
Media and supplements for cell culture were purchased from Euroclone (Euroclone, Pero, MI, Italy) and plasticware from Corning (Corning Life Sciences, NY, USA). U251MG (Astrocytoma IV WHO grade) cells were purchased from Banca Biologica and Cell Factory (Banca Biologica and Cell Factory, Genoa, Italy). U251MG were routinely maintained in minimum essential medium with Earle's balanced salt solution (MEM/EBSS) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutammine, 1 mM sodium pyruvate, 1% nonessential aminoacids, 100 unitsÁmL À1 penicillin, and 100 lgÁmL À1 streptomycin and grown at 37°C in a 5% CO2 95% air atmosphere. U251MG doubling time was 31 AE 1 and were maintained in culture by routinely seeding them at 10 4 cellsÁcm À2 , two times per week.
RHPS4 and treatments
The pentacyclic acridine, 3,11-difluoro-6,8,13-trimethyl8Hquino[4,3,2-kl]acridinium methosulfate (RHPS4) 10 mM stock solution was prepared in dimethyl sulfoxide (DMSO). The drug was always added to the cells 24 h after plating. An appropriate volume of sterile DMSO was always used as a negative control (not shown). Drug dilutions were freshly prepared periodically before each set of experiments.
Irradiation conditions and combined treatments
Cell irradiations with carbon ions were performed at CNAO using the synchrotron-based clinical scanning beams and one of the available fixed horizontal beam lines [35, 36] . Flasks were vertically placed inside a motorized water phantom at the isocenter, at the middle (i.e., 15 cm depth in water) of a spread-out Bragg peak (SOBP) (Fig. 6 ) and irradiation was performed at room temperature (around 21°C). The SOBP, homogeneous in terms of absorbed dose to water and 6 cm thick (from 12 to 18 cm depth in water), was achieved with active beam energy modulation and pencil beam scanning modality, using 31 different energies in the range of 246-312 MeVÁlm À1 . The dose-averaged linear energy transfer (LET) at the depth of 15 cm was equal to 46 keVÁlm À1 . Samples were irradiated at different doses (0-4 Gy).
RHPS4 and carbon ions combined treatments were always performed treating cells for 120 h with 0.2 lM RHPS4 and then irradiating with doses comprised between 0.5 and 4 Gy depending on the endpoint analyzed. 
Colony forming assay
To evaluate clonogenic survival, untreated and RHPS4-treated U251MG cells were irradiated with 0.5-4 Gy of carbon ions and then plated at appropriate concentrations in T25 culture flasks in quintuplicate. After 15 days, cells were fixed/stained with an aqueous solution containing 0.25% (w/v) crystal violet, 70% (v/v) methanol, and 3% (v/v) formaldehyde and counted. Only colonies made of > 50 cells were included in the quantification. For each treatment, the surviving fraction (SF) was assessed according to the formula: SF = number of colonies formed/number of cells seeded. Plating efficiency was represented by the SF in untreated conditions. Results are the mean of three independent experiments. Synergistic interaction between RHPS4 and IR was tested using the model proposed by Lutterbojer and coauthors [24] .
53BP1 and cH2AX coimmunostaining
Cells adherent to the bottom of chamber slides (Nunc, IL, USA) were exposed to 2 and 4 Gy of carbon ions, collected after 1, 4, and 24 h and stained for cH2AX and 53BP1 as previously described [37] . Briefly cells were fixed with 4% paraformaldehyde, permeabilized with 0.5% Triton X-100, blocked in PBS/BSA1% and coimmunostained using cH2AX (Millipore) and 53BP1 (Novus Biologicals, CO, USA) primary antibodies followed by anti-mouse Alexa 546 and anti-rabbit Alexa 488 secondary antibodies (1 : 400) (Invitrogen, CA, USA).
To determine the fraction of 53BP1 and c-H2AX remaining at 4 and 24 h, values for nonirradiated samples were subtracted from irradiated samples and these were normalized to data obtained after 1 h. The frequency of both cH2AX and 53BP1 foci was scored in 100 nuclei in at least three independent experiments.
Collection of chromosome spreads
Chromosome spreads were obtained from samples exposed to 1 and 2 Gy and from sham irradiated samples following 30-min incubation in 30 nM calyculin-A (Wako, Osaka, Japan). Spreads of prematurely condensed chromosomes (PCC) were prepared after 24 h from irradiation following standard cytogenetic procedures.
mFISH
Fixed cells were dropped onto glass slides and hybridized with the 24XCyte Human Multicolour FISH Probe Kit (MetaSystems GmbH, Altlussheim, Germany), as previously described [32] . Briefly, the slides were denatured in 0.07N NaOH and then rinsed in a graded ethanol series. The probe mix was denatured using a MJ mini personal thermal cycler (Bio-Rad laboratories, Hercules, CA, USA) following program: 5 min at 75°C, 30 s at 10°C, and 30 min at 37°C. Slides and probe were then hybridized in a humidified chamber at 37°C for 48 h, washed in 4 9 saline-sodium citrate (SSC) buffer and counterstained with DAPI. The analysis was performed using the ISIS software (MetaSystems). For each sample, the total number of chromosomal exchanges and fragments was counted to calculate the frequency of breaks induced by the different treatments. Moreover, the frequency of complex chromosomal exchanges (exchanges that involve two or more chromosome with three or more breakpoints) and C-ratio (ratio of complex vs simple exchanges) were calculated. At least 100 cells were analyzed in two independent experiments (at least 50 cells for each experiment).
Pan-centromeric and telomeric FISH
Pan-centromeric and telomeric FISH was performed as previously described [38] . Telomeres and centromeres were stained using a Cy3-linked telomeric peptide nucleic acid (PNA) probe (N-term-AATCCCAATCCCAATCCC-Cterm) and an Alexa 488-linked pan-centromeric PNA probe (N-term-AAACACTCTTTTTGTAGA-C-term) (Panagene, Korea), respectively. Images were taken at 63 9 magnification using a Zeiss Axio Imager M1 microscope. For each sample, the frequency (events/cell) of dicentrics and telomere fusions was counted in at least 100 cells in two independent experiments (at least 50 cells for each experiment). Dicentrics were scored when a continuous chromosome displayed two marked centromeres, whereas telomere fusions were scored when a dicentric displayed a double telomeric signal on both chromatids at the junction site. Because we cannot discriminate between telomere-telomere fusions (TF) (events in which two dysfunctional telomeres rejoins together) and telomere-DSB fusions (T-DSB) (events in which a dysfunctional telomere rejoins with a radio-induced DSB), we grouped both chromosomal aberration frequencies in the category TF + T-DSB (Fig. 4A,B) . 
Flow cytometry analysis
